Lobby organisation
W. L. Gore & Associates GmbH
Company · Chemicals & manufacturing · HQ: Germany · Transparency Register entry
As of 7 November 2026, W. L. Gore & Associates GmbH appears in 9 declared MEP meetings (8 different MEPs), most often with European Conservatives & Reformists.
In their own words
“W. L. Gore & Associates GmbH (Gore) is the German subsidiary of W. L. Gore & Associates, Inc., headquartered in Newark, Delaware, USA. Founded in 1958, Gore is a global materials science company with operations on five continents and a portfolio of thousands of products serving diverse industries.”
Read the rest of the statementShow less of the statement
“The company generates annual revenues of about $5.3 billion and remains privately held. With around 13,000 employees worldwide, known as Associates, Gore fosters a distinctive culture of collaboration and shared ownership. Gore has built a legacy not only as an innovative company, but as one that innovates with purpose. “Together, improving life” is the guiding principle behind our company’s strategy and long-term commitment. Guided by this promise, Gore maintains an ongoing, fact-based, and transparent dialogue with policymakers and opinion leaders in government, academia, industry, civil society organizations (NGOs), and the broader public.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 9 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2025–2026. Bar length is relative to its busiest year (6 in 2026). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 9 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 8 Jul 2026 | Aurelijus Veryga | Revision of the Medical Device Regulation and Access to Medical Technologies |
| 5 May 2026 | Tomislav Sokol | Health Policy |
| 1 Apr 2026 | Oliver Schenk | PFAS impact on cardiovascular medical devices |
| 1 Apr 2026 | Oliver Schenk | PFAS and cardiovascular medical devices |
| 28 Jan 2026 | Alexandr Vondra | PFAS |
| 28 Jan 2026 | Ondřej Krutílek | PFAS |
| 1 Oct 2025 | Beatrice Timgren | PFAS restriction proposal |
| 23 Sep 2025 | Victor Negrescu | Meeting with MedTech Europe Cardiovascular Sector Group |
| 15 Jul 2025 | Angelika Niebler | European Defence Policies, EU Defence Readiness Omnibus |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.